Search Results

63 search results found

Cellino Biotech, Inc.

Cambridge, MA

Biotechnology

Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More
AgTech Workshop 2018 - Welcome

September 26, 2018 | Startup Exchange Video | Duration: 3:26

James Gado - Welcome
Tue, June 20, 2023 | Conference

2023 MIT London Symposium - Startup Exchange Lightning Talks

BT - One Braham (UK)

Startup Lightning Talks - 2023 MIT London Symposium: Value, Values, and Future Platforms (9:00AM - 4:15PM)
DeepCure Inc.

Boston, MA

Biotechnology

DeepCure develops disruptive Artificial Intelligence technology to revolutionize pharmaceutical development. The pharma industry is undoubtedly one of the world's largest, with worldwide revenues topping one trillion US dollars. However, its effectiveness is in question, as the exponentially... More

Keywords:

Artificial Intelligence, Deep Learning, Drug discovery, drug development, Biotechnology, Generative Drug Design, AI Driven Lead Optimization, Lead Discovery, Computational Chemistry, Beyond State-of-Art Machine Learning
Past Deadline: Jun 21, 2021

P&G Seeks Startups for 2 Innovation Briefs

partnership

P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
DUST Identity

Newton, MA

Technology

DUST -- the Diamond Uncloneable Security Tag -- is a proprietary technology which utilizes nanodiamonds to create an unclonable identity layer on any object. An optical scanner and cloud-based infrastructure provides an interface to the object identity and provenance. DUST ensures that trusted data... More

Keywords:

#supplychain #security #nanotech #cybersecurity #IoT #blockchain #counterfeit #trackandtrace
Cracking Cancer 2.0 - Panel Discussion

December 7, 2017 | Startup Exchange Video | Duration: 47:30

Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
BioBright

September 26, 2016 | Startup Exchange Video | Duration: 15:7

Charles Fracchia, Founder, BioBright
Past Deadline: Feb 25, 2020

Anglo American seeking startups for February visit

meeting

Anglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells

Search Results

Filter Results